PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15545637

RNA interference using boranophosphate siRNAs: structure-activity relationships.

Allison H S Hall·Jing Wan·Erin E Shaughnessy·Barbara Ramsay Shaw·Kenneth A Alexander
View original source ↗Export metadata ↓

Abstract

In RNA interference (RNAi), short double-stranded RNA (known as siRNA) inhibits expression from homologous genes. Clinical or pre-clinical use of siRNAs is likely to require stabilizing modifications because of the prevalence of intracellular and extracellular nucleases. In order to examine the effect of modification on siRNA efficacy and stability, we developed a new method for synthesizing stereoregular boranophosphate siRNAs. This work demonstrates that boranophosphate siRNAs are consistently more effective than siRNAs with the widely used phosphorothioate modification. Furthermore, boranophosphate siRNAs are frequently more active than native siRNA if the center of the antisense strand is not modified. Boranophosphate modification also increases siRNA potency. The finding that boranophosphate siRNAs are at least ten times more nuclease resistant than unmodified siRNAs may explain some of the positive effects of boranophosphate modification. The biochemical properties of boranophosphate siRNAs make them promising candidates for an RNAi-based therapeutic.

Explore related subjects

Boron CompoundsHeLa CellsHumansPhosphatesRNA InterferenceRNA, MessengerRNA, Small InterferingRibonucleasesStructure-Activity RelationshipThionucleotidesJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.Research Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Allison H S Hall, Jing Wan, Erin E Shaughnessy, Barbara Ramsay Shaw, Kenneth A Alexander. 2004-11-15. RNA interference using boranophosphate siRNAs: structure-activity relationships.. https://doi.org/10.1093/nar%2Fgkh936

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Tetrahedral boron chemistry for the preparation of highly efficient "cascatelle" devices.

The replacement of the two fluorine atoms on the boron center of the well-known Bodipy fluorophore by functionalized acetylenic groups opens the way to a new family of highly luminescent, redox active, and stable fluorophores termed "E-Bodipy" species. The substitution is effective for ethynyl-lithium reagents incorporating tolyl, naphthyl, pyrenyl, fluorenyl, and terpyridinyl units. The protocol also tolerates the presence of various functional groups in the dipyrromethene meso position such as pyrene, phenylethynylpyrene, 4'-terpyridine, and iodophenyl. The last of these is particularly useful for a further coupling reaction enabling introduction of a flexible arm bearing a succinimidyl unit reactive toward primary amines. X-ray structure determinations of two E-Bodipy compounds confirm the introduction of the ethynyl units and show the boron atoms to have a distorted tetrahedral environment, with B-C(ethynyl) approximately 1.59 A and both boron atoms lying essentially in the mean planes of the dipyrromethene units. All the new compounds show intense electronic absorption bands (epsilon 60,000-70,000 M-1 cm-1), high quantum yields (>80%), and slow rates of nonradiative decay. Absorption by the aromatic substituents results in a "cascatelle" process leading to emission exclusively through the boradiazaindacene entity and thus large virtual Stokes' shift (>10,000 cm-1). The new compounds are also redox active, with the formation of both Bodipy+* and Bodipy-* occurring more readily than for F-Bodipy species. The molecules in their excited states are strong reducing agents.

Boron Compounds↗
PubMed2007

Characterization of a BODIPY-labeled fluorescent fatty acid analogue. Binding to fatty acid-binding proteins, intracellular localization, and metabolism.

The BODIPY-labeled fatty acid analogues are a useful addition to the tools employed to study the cellular uptake and metabolism of lipids. In this study, we show that BODIPY FL C(16) binds to purified liver and intestinal fatty acid-binding proteins with high affinity at a site similar to that for the physiological fatty acid oleic acid. Further, in human intestinal Caco-2 cells BODIPY FL C(16) co-localizes extensively with mitochondria, endoplasmic reticulum/Golgi, and L-FABP. Virtually no esterification of BODIPY FL C(16) was observed under the experimental conditions employed. We conclude that BODIPY FL C(16) may be a useful tool for studying the distribution and function of FABPs in a cellular environment.

Boron Compounds↗